Literature DB >> 17724080

Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B.

Mirela Delibegovic1, Kendra K Bence, Nimesh Mody, Eun-Gyoung Hong, Hwi Jin Ko, Jason K Kim, Barbara B Kahn, Benjamin G Neel.   

Abstract

Obesity and type 2 diabetes are characterized by insulin resistance. Mice lacking the protein-tyrosine phosphatase PTP1B in all tissues are hypersensitive to insulin but also have diminished fat stores. Because adiposity affects insulin sensitivity, the extent to which PTP1B directly regulates glucose homeostasis has been unclear. We report that mice lacking PTP1B only in muscle have body weight and adiposity comparable to those of controls on either chow or a high-fat diet (HFD). Muscle triglycerides and serum adipokines are also affected similarly by HFD in both groups. Nevertheless, muscle-specific PTP1B(-/-) mice exhibit increased muscle glucose uptake, improved systemic insulin sensitivity, and enhanced glucose tolerance. These findings correlate with and are most likely caused by increased phosphorylation of the insulin receptor and its downstream signaling components. Thus, muscle PTP1B plays a major role in regulating insulin action and glucose homeostasis, independent of adiposity. In addition, rosiglitazone treatment of HFD-fed control and muscle-specific PTP1B(-/-) mice revealed that rosiglitazone acts additively with PTP1B deletion. Therefore, combining PTP1B inhibition with thiazolidinediones should be more effective than either alone for treating insulin-resistant states.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17724080      PMCID: PMC2169063          DOI: 10.1128/MCB.00959-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  29 in total

Review 1.  Cellular mechanisms of insulin resistance.

Authors:  G I Shulman
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 2.  The insulin signalling pathway.

Authors:  Jose M Lizcano; Dario R Alessi
Journal:  Curr Biol       Date:  2002-04-02       Impact factor: 10.834

3.  Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.

Authors:  A Zisman; O D Peroni; E D Abel; M D Michael; F Mauvais-Jarvis; B B Lowell; J F Wojtaszewski; M F Hirshman; A Virkamaki; L J Goodyear; C R Kahn; B B Kahn
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

Review 4.  PTP1B: from the sidelines to the front lines!

Authors:  Nicholas K Tonks
Journal:  FEBS Lett       Date:  2003-07-03       Impact factor: 4.124

Review 5.  PTP1B and TC-PTP: novel roles in immune-cell signaling.

Authors:  Paul D Simoncic; C Jane McGlade; Michel L Tremblay
Journal:  Can J Physiol Pharmacol       Date:  2006-07       Impact factor: 2.273

6.  Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes.

Authors:  A M Fernández; J K Kim; S Yakar; J Dupont; C Hernandez-Sanchez; A L Castle; J Filmore; G I Shulman; D Le Roith
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

7.  Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle.

Authors:  J K Kim; M D Michael; S F Previs; O D Peroni; F Mauvais-Jarvis; S Neschen; B B Kahn; C R Kahn; G I Shulman
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

8.  PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice.

Authors:  Bradley A Zinker; Cristina M Rondinone; James M Trevillyan; Rebecca J Gum; Jill E Clampit; Jeffrey F Waring; Nancy Xie; Denise Wilcox; Peer Jacobson; Leigh Frost; Paul E Kroeger; Regina M Reilly; Sandra Koterski; Terry J Opgenorth; Roger G Ulrich; Seth Crosby; Madeline Butler; Susan F Murray; Robert A McKay; Sanjay Bhanot; Brett P Monia; Michael R Jirousek
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

9.  Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis.

Authors:  Cristina M Rondinone; James M Trevillyan; Jill Clampit; Rebecca J Gum; Cathy Berg; Paul Kroeger; Leigh Frost; Bradley A Zinker; Regina Reilly; Roger Ulrich; Madeline Butler; Brett P Monia; Michael R Jirousek; Jeffrey F Waring
Journal:  Diabetes       Date:  2002-08       Impact factor: 9.461

10.  PTP1B antisense-treated mice show regulation of genes involved in lipogenesis in liver and fat.

Authors:  Jeffrey F Waring; Rita Ciurlionis; Jill E Clampit; Sherry Morgan; Rebecca J Gum; Robert A Jolly; Paul Kroeger; Leigh Frost; James Trevillyan; Bradley A Zinker; Michael Jirousek; Roger G Ulrich; Cristina M Rondinone
Journal:  Mol Cell Endocrinol       Date:  2003-05-30       Impact factor: 4.102

View more
  75 in total

1.  T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice.

Authors:  K Loh; T L Merry; S Galic; B J Wu; M J Watt; S Zhang; Z-Y Zhang; B G Neel; T Tiganis
Journal:  Diabetologia       Date:  2011-11-29       Impact factor: 10.122

Review 2.  Transgenic mouse models resistant to diet-induced metabolic disease: is energy balance the key?

Authors:  Laura A A Gilliam; P Darrell Neufer
Journal:  J Pharmacol Exp Ther       Date:  2012-06-13       Impact factor: 4.030

3.  Neuronal protein tyrosine phosphatase 1B deficiency results in inhibition of hypothalamic AMPK and isoform-specific activation of AMPK in peripheral tissues.

Authors:  Bingzhong Xue; Thomas Pulinilkunnil; Incoronata Murano; Kendra K Bence; Huamei He; Yasuhiko Minokoshi; Kenji Asakura; Anna Lee; Fawaz Haj; Noboru Furukawa; Karyn J Catalano; Mirela Delibegovic; James A Balschi; Saverio Cinti; Benjamin G Neel; Barbara B Kahn
Journal:  Mol Cell Biol       Date:  2009-06-15       Impact factor: 4.272

4.  Disruption of protein-tyrosine phosphatase 1B expression in the pancreas affects β-cell function.

Authors:  Siming Liu; Yannan Xi; Ahmed Bettaieb; Kosuke Matsuo; Izumi Matsuo; Rohit N Kulkarni; Fawaz G Haj
Journal:  Endocrinology       Date:  2014-06-23       Impact factor: 4.736

5.  Liver-specific deletion of protein tyrosine phosphatase (PTP) 1B improves obesity- and pharmacologically induced endoplasmic reticulum stress.

Authors:  Abdelali Agouni; Nimesh Mody; Carl Owen; Alicja Czopek; Derek Zimmer; Mohamed Bentires-Alj; Kendra K Bence; Mirela Delibegović
Journal:  Biochem J       Date:  2011-09-01       Impact factor: 3.857

Review 6.  Protein-tyrosine phosphatase 1B substrates and metabolic regulation.

Authors:  Jesse Bakke; Fawaz G Haj
Journal:  Semin Cell Dev Biol       Date:  2014-09-28       Impact factor: 7.727

Review 7.  Protein tyrosine phosphatases (PTPs) in diabetes: causes and therapeutic opportunities.

Authors:  Chiranjeev Sharma; Youllee Kim; Dohee Ahn; Sang J Chung
Journal:  Arch Pharm Res       Date:  2021-02-15       Impact factor: 4.946

8.  De novo RNA sequence assembly during in vivo inflammatory stress reveals hundreds of unannotated lincRNAs in human blood CD14+ monocytes and in adipose tissue.

Authors:  Chenyi Xue; Xuan Zhang; Hanrui Zhang; Jane F Ferguson; Ying Wang; Christine C Hinkle; Mingyao Li; Muredach P Reilly
Journal:  Physiol Genomics       Date:  2017-04-07       Impact factor: 3.107

9.  Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.

Authors:  Janice M Zabolotny; Young-Bum Kim; Laura A Welsh; Erin E Kershaw; Benjamin G Neel; Barbara B Kahn
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

10.  T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis.

Authors:  Atsushi Fukushima; Kim Loh; Sandra Galic; Barbara Fam; Ben Shields; Florian Wiede; Michel L Tremblay; Matthew J Watt; Sofianos Andrikopoulos; Tony Tiganis
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.